Liberty BioSecurity
  • Home
  • Our Team
  • Sciences
    • Novel Biology >
      • Isolate Program
    • Bioinformatics
  • Media
  • Careers
  • Contact
Access Octomono Masonry Settings

Media

Dr. Kyle Landry presents at the EPA International Decontamination Research and Development Conference

5/10/2018

 
Dr. Kyle Landry, Chief Scientist at Liberty Biosecurity, presented at the U.S. Environmental Protection Agency’s (EPA’s) Office of Research and Development’s National Homeland Security Research Center (ORD/NHSRC) regarding the use of novel extremophilic enzymes for the removal of biofilms relevant to space flight.
Liberty believes that use of these extremophiles could eradicate biofilms that contaminate critical systems used in space flight such as water pipes, air ducts, and life support while minimizing corrosive damage caused by traditional decontamination methods. 
Picture

Comments are closed.

    Categories

    All
    Interviews
    Press Releases
    Publications
    Videos
    White Papers

    Archives

    February 2021
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    February 2020
    January 2020
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    April 2019
    November 2018
    October 2018
    August 2018
    May 2018
    April 2018
    March 2018

Home
Our Team
Sciences
Media
Careers

Contact​
Established in 2014, Liberty Biosecurity is a privately-owned entity that in 2016 became a proud founding member of the EdenRoc Sciences family of life sciences companies and investments. Liberty Biosecurity Pty Ltd (Australia) was founded in 2016 and is registered under ABN 42612486325
  • Home
  • Our Team
  • Sciences
    • Novel Biology >
      • Isolate Program
    • Bioinformatics
  • Media
  • Careers
  • Contact